Decent topline growth but concern remains on the PAT margin front which seems to be on a decline the trend, less than 2% for FY 2022, which has dragged the ROCE to 25% from 32% for earlier FY. Because of the impact on margin front profitability is still not justifying the exorbitant valuation.